Dose Launches Clinically Validated Liquid Supplement for Blood Pressure
News related to:Dose · 3 min read
NEW YORK, Sept. 28, 2026 /CourierPR/ -- Dose, a clinically-backed supplement brand, has launched a new liquid supplement designed to support healthy blood pressure, blood flow, and vascular function. The product, Dose for Blood Pressure, is the company's first new product innovation since 2022, following an 18-month development process that included over 100 iterations and extensive scientific and clinical testing.
Dose for Blood Pressure is a doctor-formulated daily liquid supplement that combines a proprietary Veldt Grape & Turmeric Blend with science-backed CoQ10, grapeseed, and folate. These ingredients are designed to provide complementary support across healthy blood flow, vascular function, cellular and heart health, antioxidant support, and cardiovascular wellness. The launch marks a significant next chapter for Dose, expanding the brand's science-backed approach beyond liver health and cholesterol to another important, and often silent, marker of long-term health.
The new supplement has been clinically validated through a randomized, double-blind, placebo-controlled study. The study, based on 1-2 servings, showed a statistically significant and meaningful positive impact on both systolic and diastolic blood pressure. Specifically, 91% of participants showed a positive impact in systolic blood pressure, and 74% of participants showed a positive impact in diastolic blood pressure. These findings complement established approaches like the DASH diet and regular exercise.
Dose's founder, Vasu Goyal, emphasized the importance of supporting the body's core systems quietly powering the body.
Blood pressure was a natural next step in Dose's expansion into the core systems and health markers that can meaningfully affect long-term health without producing obvious signs. Like liver health and cholesterol, changes in blood pressure can happen quietly, making it an important area for proactive, consistent support. As Dose's first new product innovation since 2022, Dose for Blood Pressure reflects the brand's highly intentional approach to product development, including 18 months spent refining the formulation through over 100 iterations, and putting it through extensive scientific and clinical testing before bringing it to market.
Rather than relying on a single ingredient or pathway, Dose engineered a multi-mechanism formulation combining a proprietary Veldt Grape & Turmeric Blend with science-backed CoQ10, grapeseed, and folate. Together, the ingredients provide complementary support across healthy blood flow and vascular function, cellular and heart health, antioxidant support, and cardiovascular wellness. Dose also tackled one of the category's key scientific challenges: delivering a clinically backed botanical blend in a stable, absorbable, and great-tasting liquid. Using its proprietary formulation and absorption platform, Dose developed the formula in its signature liquid format and went beyond ingredient-level research to clinically evaluate the finished Dose for Blood Pressure formulation, providing clinical validation of the formula as a whole, not just its individual ingredients.
In a randomized, double-blind, placebo-controlled clinical study based on 1-2 servings, Dose for Blood Pressure showed a statistically significant and meaningful positive impact in both systolic and diastolic blood pressure. Study findings included: 91% of participants showed a positive impact in systolic blood pressure, and 74% of participants showed a positive impact in diastolic blood pressure. These results complement established approaches like the DASH diet and regular exercise.
Dose for Blood Pressure will be available exclusively on dosedaily.co starting August 31. The product will be offered in two sizes: a 16 fl oz bottle (8 servings), available as a three-pack for $90 or six-pack for $160, and a 2 fl oz bottle (1 serving), available individually for $4.99 or as a 24-pack for $99. The formula is vegan, kosher, gluten-free, and non-GMO.
The launch of Dose for Blood Pressure marks the next phase in the evolution of the Dose brand, expanding it from a company primarily known for liver health into a broader platform supporting the core systems quietly powering the body. Anchored by the brand idea "Healthy Happens Quietly," the evolution reflects a simple truth: consumers can't necessarily feel their liver filtering, cholesterol changing, or blood pressure rising, yet these unseen changes can have a meaningful impact on long-term health. Through an expanded portfolio, greater emphasis on clinical research, and an evolved brand experience, Dose is helping consumers take proactive daily action before their bodies ask them to.